Forcing nonamyloidogenic beta-synuclein to fibrillate.
The fibrillation and aggregation of alpha-synuclein is a key process in the formation of intracellular inclusions, Lewy bodies, in substantia nigral neurons and, potentially, in the pathology of Parkinson's disease and several other neurodegenerative disorders. Alpha-synuclein and its homologue beta-synuclein are both natively unfolded proteins that colocalize in presynaptic terminals of neurons in many regions of the brain, including those of dopamine-producing cells of the substantia nigra. Unlike its homologue, beta-synuclein does not form fibrils and has been shown to inhibit the fibrillation of alpha-synuclein. In this study, we demonstrate that fast and efficient aggregation and fibrillation of beta-synuclein can be induced in the presence of a variety of factors. Certain metals (Zn(2+), Pb(2+), and Cu(2+)) induce a partially folded conformation of beta-synuclein that triggers rapid fibrillation. In the presence of these metals, mixtures of alpha- and beta-synucleins exhibited rapid fibrillation. The metal-induced fibrillation of beta-synuclein was further accelerated by the addition of glycosaminoglycans or high concentrations of macromolecular crowding agents. Beta-synuclein also rapidly formed soluble oligomers and fibrils in the presence of pesticides, whereas the addition of low concentrations of organic solvents induced formation of amorphous aggregates. These new findings demonstrate the potential effect of environmental pollutants in generating an amyloidogenic, and potentially neurotoxic, conformation, in an otherwise benign protein.
Yamin
Ghiam
G
Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, USA.
Munishkina
Larissa A
LA
Karymov
Mikhail A
MA
Lyubchenko
Yuri L
YL
Uversky
Vladimir N
VN
Fink
Anthony L
AL
D000682:Amyloid / Q000737:chemistry* / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D002942:Circular Dichroism; D003300:Copper / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000494:pharmacology; D006801:Humans; D007854:Lead / Q000494:pharmacology; D018625:Microscopy, Atomic Force; D009419:Nerve Tissue Proteins / Q000737:chemistry* / Q000378:metabolism* / Q000648:ultrastructure; D010575:Pesticides / Q000494:pharmacology; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D012997:Solvents; D017550:Spectroscopy, Fourier Transform Infrared; D051843:Synucleins; D015032:Zinc / Q000494:pharmacology; D051844:alpha-Synuclein; D051846:beta-Synuclein
D000682:Amyloid; D006025:Glycosaminoglycans; D009419:Nerve Tissue Proteins; D010575:Pesticides; C497604:SNCA protein, human; C497607:SNCB protein, human; D012997:Solvents; D051843:Synucleins; D051844:alpha-Synuclein; D051846:beta-Synuclein; C020341:glucosaminoglycans; D007854:Lead; D003300:Copper; D015032:Zinc